BioAge Labs, Inc. (BIOA) has a market capitalization of $596.19M and trades at $16.57. The 52-week range is 2.88-24.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -7.4, Earnings Per Share (EPS) of $-2.24, annual revenue of $9M.
The stock has a beta of 1.24, operates in the Healthcare sector.
